- Home
- CDIO vs SPRC Comparison
CDIO vs SPRC Comparison
Compare CDIO & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- SPRC
- Stock Information
- Founded
- CDIO 2017
- SPRC 2004
- Country
- CDIO United States
- SPRC Israel
- Employees
- CDIO N/A
- SPRC N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- SPRC Health Care
- Exchange
- CDIO Nasdaq
- SPRC Nasdaq
- Market Cap
- CDIO 8.0M
- SPRC 7.3M
- IPO Year
- CDIO N/A
- SPRC N/A
- Fundamental
- Price
- CDIO $4.23
- SPRC $3.82
- Analyst Decision
- CDIO
- SPRC
- Analyst Count
- CDIO 0
- SPRC 0
- Target Price
- CDIO N/A
- SPRC N/A
- AVG Volume (30 Days)
- CDIO 47.5K
- SPRC 6.9M
- Earning Date
- CDIO 11-12-2025
- SPRC 01-01-0001
- Dividend Yield
- CDIO N/A
- SPRC N/A
- EPS Growth
- CDIO N/A
- SPRC N/A
- EPS
- CDIO N/A
- SPRC N/A
- Revenue
- CDIO $19,507.00
- SPRC $1,306,000.00
- Revenue This Year
- CDIO $1,434.82
- SPRC N/A
- Revenue Next Year
- CDIO $4,661.91
- SPRC N/A
- P/E Ratio
- CDIO N/A
- SPRC N/A
- Revenue Growth
- CDIO N/A
- SPRC N/A
- 52 Week Low
- CDIO $3.22
- SPRC $1.75
- 52 Week High
- CDIO $53.10
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- CDIO 50.58
- SPRC 47.14
- Support Level
- CDIO $4.03
- SPRC $3.23
- Resistance Level
- CDIO $4.66
- SPRC $4.85
- Average True Range (ATR)
- CDIO 0.35
- SPRC 0.58
- MACD
- CDIO -0.01
- SPRC -0.13
- Stochastic Oscillator
- CDIO 40.38
- SPRC 15.25
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.